CO201 Persistency on Conventional Synthetic DMARDS without Evidence of Rheumatoid Arthritis Control; Identifying Populations That May Benefit from Availability of Lower-Cost TNFi Biosimilars
Abstract
Authors
A. Frick J. Broestl K. Cox K. Milligan D. Persons S. Milligan